CN102205067A - 一种治疗慢性荨麻疹的中药组合物 - Google Patents
一种治疗慢性荨麻疹的中药组合物 Download PDFInfo
- Publication number
- CN102205067A CN102205067A CN2011101556410A CN201110155641A CN102205067A CN 102205067 A CN102205067 A CN 102205067A CN 2011101556410 A CN2011101556410 A CN 2011101556410A CN 201110155641 A CN201110155641 A CN 201110155641A CN 102205067 A CN102205067 A CN 102205067A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- semen
- portions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 30
- 206010052568 Urticaria chronic Diseases 0.000 title claims abstract description 19
- 208000024376 chronic urticaria Diseases 0.000 title claims abstract description 19
- 239000000203 mixture Substances 0.000 title claims abstract description 15
- 210000000582 semen Anatomy 0.000 claims abstract description 35
- 241000555682 Forsythia x intermedia Species 0.000 claims abstract description 3
- 241001071795 Gentiana Species 0.000 claims abstract description 3
- 241000756943 Codonopsis Species 0.000 claims description 11
- 241000222640 Polyporus Species 0.000 claims description 11
- 241000244155 Taenia Species 0.000 claims description 11
- 239000002994 raw material Substances 0.000 claims description 4
- 241000206501 Actaea <angiosperm> Species 0.000 claims description 2
- 235000014435 Mentha Nutrition 0.000 claims description 2
- 241001072983 Mentha Species 0.000 claims description 2
- 241001530126 Scrophularia Species 0.000 claims description 2
- 241000405217 Viola <butterfly> Species 0.000 claims description 2
- 241000132012 Atractylodes Species 0.000 abstract 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 241000906579 Actaea cimicifuga Species 0.000 abstract 1
- 244000144725 Amygdalus communis Species 0.000 abstract 1
- 235000011437 Amygdalus communis Nutrition 0.000 abstract 1
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 abstract 1
- 235000017491 Bambusa tulda Nutrition 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000212948 Cnidium Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 241000222684 Grifola Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 241000266847 Mephitidae Species 0.000 abstract 1
- 244000082204 Phyllostachys viridis Species 0.000 abstract 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 244000081426 Ranunculus ficaria Species 0.000 abstract 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 abstract 1
- 244000153955 Reynoutria sachalinensis Species 0.000 abstract 1
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 abstract 1
- 240000006688 Telosma cordata Species 0.000 abstract 1
- 235000017352 Telosma cordata Nutrition 0.000 abstract 1
- 235000020224 almond Nutrition 0.000 abstract 1
- 239000011425 bamboo Substances 0.000 abstract 1
- 235000005301 cimicifuga racemosa Nutrition 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 description 17
- 230000001717 pathogenic effect Effects 0.000 description 15
- 208000003251 Pruritus Diseases 0.000 description 14
- 235000009508 confectionery Nutrition 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 13
- 210000000952 spleen Anatomy 0.000 description 13
- 208000002193 Pain Diseases 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 210000003734 kidney Anatomy 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 10
- 210000002784 stomach Anatomy 0.000 description 10
- 206010062717 Increased upper airway secretion Diseases 0.000 description 9
- 230000007812 deficiency Effects 0.000 description 9
- 208000026435 phlegm Diseases 0.000 description 9
- 206010011224 Cough Diseases 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 244000052769 pathogen Species 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 208000011580 syndromic disease Diseases 0.000 description 7
- 210000003932 urinary bladder Anatomy 0.000 description 7
- 206010030113 Oedema Diseases 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 210000000232 gallbladder Anatomy 0.000 description 6
- 206010037844 rash Diseases 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 5
- 208000024780 Urticaria Diseases 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 206010063409 Acarodermatitis Diseases 0.000 description 4
- 201000005505 Measles Diseases 0.000 description 4
- 241000447727 Scabies Species 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 244000045947 parasite Species 0.000 description 4
- 208000005687 scabies Diseases 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 208000010201 Exanthema Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 206010013990 dysuria Diseases 0.000 description 3
- 201000005884 exanthem Diseases 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 3
- 208000037920 primary disease Diseases 0.000 description 3
- 201000005404 rubella Diseases 0.000 description 3
- 206010040882 skin lesion Diseases 0.000 description 3
- 231100000444 skin lesion Toxicity 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010016807 Fluid retention Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 229960003088 loratadine Drugs 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 208000028185 Angioedema Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical class CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 235000005903 Dioscorea Nutrition 0.000 description 1
- 241000234273 Dioscorea Species 0.000 description 1
- 235000000504 Dioscorea villosa Nutrition 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- PVLJETXTTWAYEW-UHFFFAOYSA-N Mizolastine Chemical compound N=1C=CC(=O)NC=1N(C)C(CC1)CCN1C1=NC2=CC=CC=C2N1CC1=CC=C(F)C=C1 PVLJETXTTWAYEW-UHFFFAOYSA-N 0.000 description 1
- 208000025047 Non-histaminic angioedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 208000003217 Tetany Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 235000004240 Triticum spelta Nutrition 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- ILKJAFIWWBXGDU-MOGDOJJUSA-N amcinonide Chemical compound O([C@@]1([C@H](O2)C[C@@H]3[C@@]1(C[C@H](O)[C@]1(F)[C@@]4(C)C=CC(=O)C=C4CC[C@H]13)C)C(=O)COC(=O)C)C12CCCC1 ILKJAFIWWBXGDU-MOGDOJJUSA-N 0.000 description 1
- 229960003099 amcinonide Drugs 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- GXDALQBWZGODGZ-UHFFFAOYSA-N astemizole Chemical compound C1=CC(OC)=CC=C1CCN1CCC(NC=2N(C3=CC=CC=C3N=2)CC=2C=CC(F)=CC=2)CC1 GXDALQBWZGODGZ-UHFFFAOYSA-N 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229960001803 cetirizine Drugs 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229940088529 claritin Drugs 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000000938 histamine H1 antagonist Substances 0.000 description 1
- 239000003485 histamine H2 receptor antagonist Substances 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 229960001144 mizolastine Drugs 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000008203 tachypnea Diseases 0.000 description 1
- 206010043089 tachypnoea Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229940125379 topical corticosteroid Drugs 0.000 description 1
- 229940125725 tranquilizer Drugs 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110155641A CN102205067B (zh) | 2011-06-10 | 2011-06-10 | 一种治疗慢性荨麻疹的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110155641A CN102205067B (zh) | 2011-06-10 | 2011-06-10 | 一种治疗慢性荨麻疹的中药组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102205067A true CN102205067A (zh) | 2011-10-05 |
CN102205067B CN102205067B (zh) | 2012-09-12 |
Family
ID=44694310
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110155641A Expired - Fee Related CN102205067B (zh) | 2011-06-10 | 2011-06-10 | 一种治疗慢性荨麻疹的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102205067B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102698216A (zh) * | 2012-04-21 | 2012-10-03 | 王伟良 | 一种预防治疗感冒咳嗽的药物配方及其制备方法 |
CN104623371A (zh) * | 2015-02-05 | 2015-05-20 | 吉林农业科技学院 | 一种治疗荨麻疹的中药组方及其颗粒剂的制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101040962A (zh) * | 2007-04-02 | 2007-09-26 | 王翠云 | 一种内服治疗荨麻疹的中药组合物 |
CN101301461A (zh) * | 2008-06-25 | 2008-11-12 | 崔凤玉 | 一种治疗荨麻疹的药物 |
-
2011
- 2011-06-10 CN CN201110155641A patent/CN102205067B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101040962A (zh) * | 2007-04-02 | 2007-09-26 | 王翠云 | 一种内服治疗荨麻疹的中药组合物 |
CN101301461A (zh) * | 2008-06-25 | 2008-11-12 | 崔凤玉 | 一种治疗荨麻疹的药物 |
Non-Patent Citations (3)
Title |
---|
《重庆中草药研究》 20100630 莫宗成等 慢性荨麻疹的中医治疗进展 38-40 1-2 , 第01期 * |
莫宗成等: "慢性荨麻疹的中医治疗进展 ", 《重庆中草药研究》 * |
莫宗成等: "慢性荨麻疹的中医治疗进展", 《重庆中草药研究》, no. 01, 30 June 2010 (2010-06-30), pages 38 - 40 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102698216A (zh) * | 2012-04-21 | 2012-10-03 | 王伟良 | 一种预防治疗感冒咳嗽的药物配方及其制备方法 |
CN104623371A (zh) * | 2015-02-05 | 2015-05-20 | 吉林农业科技学院 | 一种治疗荨麻疹的中药组方及其颗粒剂的制备方法 |
CN104623371B (zh) * | 2015-02-05 | 2017-10-20 | 吉林农业科技学院 | 一种治疗荨麻疹的中药组方及其颗粒剂的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102205067B (zh) | 2012-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103550517B (zh) | 一种治疗肝癌的药物 | |
CN103536858B (zh) | 一种治疗类风湿性关节炎的药物 | |
CN102688420A (zh) | 一种治疗牛皮癣的中药汤剂 | |
CN104383390A (zh) | 一种治疗肺癌的中药制剂 | |
CN102631512B (zh) | 一种治疗慢性结肠炎的中药组合物 | |
CN104069162B (zh) | 一种治疗痛风性关节炎及各种骨关节疼痛的中药 | |
CN103169883B (zh) | 一种治疗小儿黄疸的中药 | |
CN103495055A (zh) | 一种用于治疗女性内分泌失调的中药汤剂及制备方法 | |
CN100579562C (zh) | 一种内服治疗便秘的中药组合物 | |
CN104107398A (zh) | 一种治疗风湿性心脏病的中药组合物 | |
CN103800842A (zh) | 一种治疗膀胱癌的中药组合物 | |
CN104383336B (zh) | 一种用于肾结石术后护理的中药制剂及制备方法 | |
CN102861296A (zh) | 治疗膝关节滑膜炎的利湿消肿丸 | |
CN102908555A (zh) | 一种治疗水肿的中药 | |
CN102205067B (zh) | 一种治疗慢性荨麻疹的中药组合物 | |
CN103720980A (zh) | 一种治疗慢性肾炎的药物 | |
CN103920046A (zh) | 一种用于治疗膀胱炎的药物及制备方法 | |
CN103263606B (zh) | 一种足浴护理治疗糖尿病足的中药组合物及应用 | |
CN102626509B (zh) | 一种治疗小儿黄疸的中药组合物 | |
CN101129718B (zh) | 治疗白癜风的中药制剂 | |
CN104547384A (zh) | 一种治疗百草枯中毒的口服液及制备方法 | |
CN103751656A (zh) | 一种治疗尿浊病的中药汤剂 | |
CN103800561A (zh) | 一种治疗肾性血尿的中药 | |
CN103212001A (zh) | 一种治疗泄泻的中药组合物 | |
CN102552824B (zh) | 用于治疗银屑病的中成药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: NANTONG YUEYUE INDUSTRY CO., LTD. Free format text: FORMER OWNER: LI KEYING Effective date: 20140626 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 262500 WEIFANG, SHANDONG PROVINCE TO: 226131 NANTONG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140626 Address after: 226131 Haimen County, Jiangsu, Nantong province government compound Patentee after: Nantong Yue Yue Industrial Co., Ltd. Address before: 262500 Shandong city of Weifang province Qingzhou City Linglong Mountain Road No. 3888 Qingzhou Invalides hospital Patentee before: Li Keying |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120912 Termination date: 20200610 |